Cargando…
CD39 Produced from Human GMSCs Regulates the Balance of Osteoclasts and Osteoblasts through the Wnt/β-Catenin Pathway in Osteoporosis
Osteoporosis is a disease in which the density and quality of bone are reduced, causing bones to become weak and so brittle that a fall or even mild stresses can cause a fracture. Current drug treatment consists mainly of antiresorptive agents that are unable to stimulate new bone formation. Our rec...
Autores principales: | Wu, Wenbin, Xiao, Zexiu, Chen, Ye, Deng, Yanan, Zeng, Donglan, Liu, Yan, Huang, Feng, Wang, Julie, Liu, Yanying, Bellanti, Joseph A., Rong, Limin, Zheng, Song Guo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264439/ https://www.ncbi.nlm.nih.gov/pubmed/32304668 http://dx.doi.org/10.1016/j.ymthe.2020.04.003 |
Ejemplares similares
-
Cytokine-scavenging nanodecoys reconstruct osteoclast/osteoblast balance toward the treatment of postmenopausal osteoporosis
por: Zhou, Yang, et al.
Publicado: (2021) -
The effect of cytokines on osteoblasts and osteoclasts in bone remodeling in osteoporosis: a review
por: Xu, Jie, et al.
Publicado: (2023) -
Screening diagnostic markers of osteoporosis based on ferroptosis of osteoblast and osteoclast
por: Cao, Zhihai, et al.
Publicado: (2023) -
Impaired osteoblast and osteoclast function characterize the osteoporosis of Snyder - Robinson syndrome
por: Albert, Jessica S, et al.
Publicado: (2015) -
Loss of menin in osteoblast lineage affects osteocyte–osteoclast crosstalk causing osteoporosis
por: Liu, Peng, et al.
Publicado: (2017)